Arcutis Biotherapeutics, Inc.ARQTNASDAQ
LOADING
|||
Switch Symbol:
Operating Income Growth Accelerating
Trending higher, above historical average.
Left:
||||
Year-over-year operating income growth rate
Latest
158.35%
↑ 1263% above average
Average (30q)
-13.62%
Historical baseline
Range
High:158.35%
Low:-221.40%
Volatility
-2788.8%
Relatively stable
| Period | Value |
|---|---|
| Q3 2025 | 158.35% |
| Q2 2025 | 40.43% |
| Q1 2025 | -221.40% |
| Q4 2024 | 80.46% |
| Q3 2024 | 21.99% |
| Q2 2024 | -58.36% |
| Q1 2024 | 48.30% |
| Q4 2023 | -65.75% |
| Q3 2023 | 44.72% |
| Q2 2023 | 12.46% |
| Q1 2023 | -11.46% |
| Q4 2022 | 34.68% |
| Q3 2022 | -59.13% |
| Q2 2022 | -5.11% |
| Q1 2022 | 12.15% |
| Q4 2021 | -24.89% |
| Q3 2021 | -35.64% |
| Q2 2021 | -16.61% |
| Q1 2021 | -5.93% |
| Q4 2020 | 11.07% |
| Q3 2020 | -7.51% |
| Q2 2020 | -24.35% |
| Q1 2020 | -120.49% |
| Q4 2019 | 11.29% |
| Q3 2019 | -71.56% |
| Q2 2019 | -22.81% |
| Q1 2019 | -16.78% |
| Q4 2018 | 22.64% |
| Q3 2018 | -152.88% |
| Q2 2018 | 0.00% |
| Q1 2018 | 0.00% |